164 related articles for article (PubMed ID: 12435716)
1. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.
Sobottka I; Cachovan G; Stürenburg E; Ahlers MO; Laufs R; Platzer U; Mack D
Antimicrob Agents Chemother; 2002 Dec; 46(12):4019-21. PubMed ID: 12435716
[TBL] [Abstract][Full Text] [Related]
2. Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.
Sobottka I; Wegscheider K; Balzer L; Böger RH; Hallier O; Giersdorf I; Streichert T; Haddad M; Platzer U; Cachovan G
Antimicrob Agents Chemother; 2012 May; 56(5):2565-9. PubMed ID: 22354306
[TBL] [Abstract][Full Text] [Related]
3. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses.
Warnke PH; Becker ST; Springer IN; Haerle F; Ullmann U; Russo PA; Wiltfang J; Fickenscher H; Schubert S
J Craniomaxillofac Surg; 2008 Dec; 36(8):462-7. PubMed ID: 18760616
[TBL] [Abstract][Full Text] [Related]
4. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
6. Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.
Al-Nawas B; Walter C; Morbach T; Seitner N; Siegel E; Maeurer M; Krummenauer F
Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):75-82. PubMed ID: 18663500
[TBL] [Abstract][Full Text] [Related]
7. [National multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens. Spanish Study Group on Moxifloxacin].
Loza E; Morosini M; Negri MC; Almaraz F; Cantón R; Baquero F
Rev Esp Quimioter; 2000 Mar; 13(1):37-43. PubMed ID: 10855023
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.
Saravolatz L; Manzor O; Check C; Pawlak J; Belian B
J Antimicrob Chemother; 2001 Jun; 47(6):875-7. PubMed ID: 11389122
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin.
Yamada M; Hatou S; Yoshida J
Eye Contact Lens; 2008 Mar; 34(2):109-12. PubMed ID: 18327047
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections.
Milazzo I; Blandino G; Musumeci R; Nicoletti G; Lo Bue AM; Speciale A
Int J Antimicrob Agents; 2002 Dec; 20(6):451-6. PubMed ID: 12458140
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Rodríguez-Avial I; Rodríguez-Avial C; Picazo JJ
Rev Esp Quimioter; 2001 Dec; 14(4):364-8. PubMed ID: 11856983
[TBL] [Abstract][Full Text] [Related]
12. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Mather R; Karenchak LM; Romanowski EG; Kowalski RP
Am J Ophthalmol; 2002 Apr; 133(4):463-6. PubMed ID: 11931779
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
Yong DE; Cheong HJ; Kim YS; Park YJ; Kim WJ; Woo JH; Lee KW; Kang MW; Choo YS
J Korean Med Sci; 2002 Dec; 17(6):737-42. PubMed ID: 12482994
[TBL] [Abstract][Full Text] [Related]
14. Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.
Lopez H; Vilches V; Scarano S; Stepanik D; Smayevsky J; Lemme L; Cardeñosa O; Ambler J; Sucari A
Int J Antimicrob Agents; 2001 Oct; 18(4):379-82. PubMed ID: 11691572
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance of subgingival species in chronic periodontitis patients.
Ardila CM; Granada MI; Guzmán IC
J Periodontal Res; 2010 Aug; 45(4):557-63. PubMed ID: 20546113
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):305-9. PubMed ID: 10385024
[TBL] [Abstract][Full Text] [Related]
17. Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.
Jones ME; Staples AM; Critchley I; Thornsberry C; Heinze P; Engler HD; Sahm DF
Antimicrob Agents Chemother; 2000 Oct; 44(10):2645-52. PubMed ID: 10991838
[TBL] [Abstract][Full Text] [Related]
18. Radiography-based score indicative for the pathogenicity of bacteria in odontogenic infections.
Cachovan G; Blessmann M; Schön G; Rother U; Heiland M; Stürenburg E; Platzer U; Sobottka I
Acta Odontol Scand; 2014 Oct; 72(7):530-6. PubMed ID: 24444257
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.
Decousser JW; Allouch PY; Courvalin P; Leclercq R;
Int J Antimicrob Agents; 2002 Sep; 20(3):186-95. PubMed ID: 12385697
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
Tomás I; Alvarez M; Limeres J; Otero JL; Saavedra E; López-Meléndez C; Diz P
Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
